天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid Struktur
353777-66-9
CAS-Nr.
353777-66-9
Englisch Name:
(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid
Synonyma:
Perindopril EP Impurity 7;Perindoprilat EP impurity 7;(2S,3aS,7aS)-1-((2S)-2-(3-cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylate;(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid;1H-Indole-2-carboxylic acid, 1-[(2S)-2-(3-cyclohexyl-2,4-dioxo-5-propyl-1-imidazolidinyl)-1-oxopropyl]octahydro-, (2S,3aS,7aS)-;(2S,3aS,7aS)-1-[(2S)-2-[(5RS)-3-cyclohexyl-2,4-dioxo-5- propylimidazolidin-1-yl]propanoyl]octahydro-1H-indole- 2-carboxylic acid;2-methylpropan-2-amine (2S,3aS,7aS)-1-((2S)-2-(3-cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylate
CBNumber:
CB32694459
Summenformel:
C24H37N3O5
Molgewicht:
447.57
MOL-Datei:
353777-66-9.mol

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid Eigenschaften

Sicherheit

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Impurity of Perindopril (P287500), an angiotensin-converting enzyme (ACE) inhibitor that exhibits antihypertensive properties.

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

(2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 13)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
QUALITY CONTROL SOLUTIONS LTD. 		0755-66853366; 13670046396
 ORDERS@QCSRM.COM China 24342 58
J & K SCIENTIFIC LTD. 010-82848833 400-666-7788
 jkinfo@jkchemical.com China 96815 76
Beijing Comparison Pharmaceutical Technology Co., Ltd 010-010-52878169 15801002657
 sales@bjcomparison.com China 5004 58
Shanghai TaoSu Biochemical Technology Co., Ltd. 021-33632979
info@tsbiochem.com China 8065 58
Shanghai Synteam Biochem CO.,ltd +86-021-58380978 +86-18017016373
 info@systeambc.com China 942 50
Shenzhen Polymeri Biochemical Technology Co., Ltd. +86-400-002-6226 +86-13028896684;
 sales@rrkchem.com China 57423 58
Wuxi Helen Biotechnology Co., Ltd., 0510-85629785 18013409632
 sales@reading-chemicals.com China 14081 58
Energy Chemical 021-58432009 400-005-6266
 marketing1@energy-chemical.com China 44806 58
Shenzhen Qingtian Biotechnology Co, Ltd. 18823167005 18162969855
 744288988@qq.com China 2629 58
Hubei Moco Chemical Co., Ltd. 18627753421 18627756402
 3001009495@qq.com China 19063 58
  • (2S,3aS,7aS)-1-[(2S)-2-(3-Cyclohexyl-2,4-dioxo-5-propyl-1-iMidazolidinyl)-1-oxopropyl]octahydro-1H-Indole-2-carboxylic Acid
  • 1H-Indole-2-carboxylic acid, 1-[(2S)-2-(3-cyclohexyl-2,4-dioxo-5-propyl-1-imidazolidinyl)-1-oxopropyl]octahydro-, (2S,3aS,7aS)-
  • (2S,3aS,7aS)-1-[(2S)-2-[(5RS)-3-cyclohexyl-2,4-dioxo-5- propylimidazolidin-1-yl]propanoyl]octahydro-1H-indole- 2-carboxylic acid
  • 2-methylpropan-2-amine (2S,3aS,7aS)-1-((2S)-2-(3-cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylate
  • (2S,3aS,7aS)-1-((2S)-2-(3-cyclohexyl-2,4-dioxo-5-propylimidazolidin-1-yl)propanoyl)octahydro-1H-indole-2-carboxylate
  • Perindopril EP Impurity 7
  • Perindoprilat EP impurity 7
  • 353777-66-9
  • Amines, Chiral Reagents, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
Copyright 2019 ? ChemicalBook. All rights reserved